Objectives: The main goal of the study was to evaluate the effectiveness and safety of radiofrequency-assisted liver resection.
Background: Liver resection is the "gold standard" for patients with resectable liver tumors. In the past years, the role of radiofrequency in liver surgery has been expanded from simple tumor ablation to its use in the technique of radiofrequency-assisted liver resection.
Methods: Patients with primary or secondary liver tumors, who underwent radiofrequency-assisted liver resection have been included into the prospective study. The acquired data underwent statistical analysis and were compared with the published results of liver resections.
Results: Between January 1, 2007 and September 30, 2009, 53 patients underwent radiofrequency-assisted liver resection. Seventy-six tumours were resected with the mean diameter of 38±19 mm. Mean peroperative blood loss was 170.8±285.4 mL and transfusions were needed postoperatively in 9.4 % cases. The mean hospital stay was 10.6±7.2 days. Postoperative complications were noted in 16.9 % patients; postoperative mortality was 1.9 %.
Conclusion: The radiofrequency-assisted liver resection represents a safe and effective way of hepatic parenchyma transaction and to hepatobiliary surgeon it offers a new way of effective transection of liver parenchyma (Tab. 2, Ref. 23).
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.4149/bll_2013_005 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Radiofrequency-assisted transection of the pancreas versus stapler in distal pancreatectomy: study protocol for a multicentric randomised clinical trial (TRANSPAIRE).
BMJ Open
November 2022
Department of Surgery, Hospital del Mar Medical Research Institute, Barcelona, Spain.
Introduction: To date, no pancreatic stump closure technique has been shown to be superior to any other in distal pancreatectomy. Although several studies have shown a trend towards better results in transection using a radiofrequency device (radiofrequency-assisted transection (RFT)), no randomised trial for this purpose has been performed to date. Therefore, we designed a randomised clinical trial, with the hypothesis that this technique used in distal pancreatectomies is superior in reducing clinically relevant postoperative pancreatic fistula (CR-POPF) than mechanical closures.
View Article and Find Full Text PDFHepatic epithelioid hemangioendothelioma (HEHE)-rare vascular malignancy mimicking cholangiocarcinoma: a case report.
Transl Gastroenterol Hepatol
October 2022
HPB Surgical Unit, Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, London, UK.
Hepatic epithelioid hemangioendothelioma (HEHE) is a rare, often misdiagnosed malignancy of vascular origin. We describe a case of a 36-year-old, who presented with a burning sensation in his chest on exercise and was believed to have bilobar intrahepatic cholangiocarcinoma. After receiving chemotherapy with partial response, the patient underwent staged resection with modified associating liver partition with portal vein ligation for staged hepatectomy (ALPPS) procedure-laparoscopic radiofrequency-assisted ALPPS (RALPPS).
View Article and Find Full Text PDFGut Barrier Disruption Secondary to Radiofrequency-Assisted Liver Parenchyma Resection in a Porcine Model.
J Gastrointest Surg
September 2022
Laboratory of Experimental Surgery and Surgical Research, School of Medicine, Democritus University of Thrace, Dragana, 68100, Alexandroupolis, Greece.
Background: Radiofrequency-assisted liver resection (RF-LR) techniques minimize intraoperative blood loss, while avoiding the Pringle maneuver. Both surgical excision and radiofrequency ablation of liver parenchyma compromise gut barrier function with subsequent bacterial translocation. The present study sought to investigate in a porcine model the impact of two RF-LR techniques on the integrity and inflammatory response of the gut barrier.
View Article and Find Full Text PDFRescue radiofrequency ablation or percutaneous ethanol injection: a strategy for failed RALPPS stage-1 in patients with cirrhosis-related hepatocellular carcinoma.
BMC Surg
May 2021
Institute of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), No. 30 Gaotanyan Main Street, Shapingba District, Chongqing, 400038, China.
Background: The future liver remnant (FLR) faces a risk of poor growth in patients with cirrhosis-related hepatocellular carcinoma (HCC) after stage-1 radiofrequency-assisted ALPPS (RALPPS). The present study presents a strategy to trigger further FLR growth using supplementary radiofrequency ablation (RFA) and percutaneous ethanol injection (PEI).
Methods: At RALPPS stage-1 the portal vein branch was ligated, followed by intraoperative RFA creating a coagulated avascular area between the FLR and the deportalized lobes.
A novel internal cold circulation radiofrequency-assisted device for liver transection.
Int J Hyperthermia
July 2021
Department of Hepatopancreatobiliary Surgery, The Affiliated Tumor Hospital of Zhengzhou University, Henan, People's Republic of China.
Purpose: To evaluate the safety and efficacy of a new internal cold circulation bipolar radiofrequency compared with Habib-4X bipolar radiofrequency device in the resection of liver tumors.
Methods: A total of 85 patients with hepatocellular carcinoma who received radiofrequency-assisted liver resection from February 2017 to January 2020 were retrospectively enrolled in our study, in which 45 patients received the new internal cold circulation bipolar radiofrequency (New-RF) and 40 patients received Habib-4X bipolar radiofrequency (Habib-4X). Primary outcome measures were the speed of liver transection, the width of coagulation tissue, hemorrhage volume, blood transfusion rate, and operation time.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!